MiNA Therapeutics Limited, the pioneer in small activating RNA therapeutics, presents preclinical proof of mechanism data on MTL‑STING as a novel cancer immunotherapy. The...
Myeloid Therapeutics, Inc., a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases, presented new late-breaking data at the American Association...
HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first- and best-in-class small molecule allosteric therapies targeting regulatory sites on proteins...
Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced the...
